A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24%
Clinical trial NCT02173249 · COMPLETED
Trial details
- NCT number
- NCT02173249
- Sponsor
- Aciex Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-08-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.